The Pathophysiology of Spontaneous Preterm Birth: Emerging Mechanisms Reviewed by the Preterm Birth International

Emmeli Mikkelsen1,2, Emmanuel Amabebe3,4, Andrea Olmos-Ortiz5

  • 1Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

Insights

Preterm birth, affecting 10% of global births, lacks effective prediction and prevention methods. Understanding parturition as an inflammatory process is key to developing new treatments for spontaneous preterm birth.

Area of Science:

  • Reproductive biology
  • Maternal-fetal medicine
  • Genetics

Background:

  • Approximately 10% of global births are preterm, posing significant maternal and neonatal health challenges.
  • Limited progress in predicting and preventing spontaneous preterm birth despite extensive research.
  • Spontaneous preterm birth necessitates a deeper understanding of its complex pathophysiology.

Purpose of the Study:

  • To review recent advancements in understanding normal and preterm human birth pathophysiology.
  • To present parturition as an inflammatory event involving multiple signaling pathways.
  • To explore novel research perspectives for preterm birth prediction and prevention.

Main Methods:

  • Review of current literature on human parturition.
  • Analysis of endocrine, paracrine, and microbiome-related pathways.
  • Discussion of mathematical modeling and machine learning applications.

Main Results:

  • Parturition is characterized as an inflammatory event impacting uterine tissues.
  • Multiple pathways, including fetal membrane senescence and vaginal microbiome, contribute to labor induction.
  • Mathematical modeling and AI can identify preterm birth risk phenotypes.

Conclusions:

  • Understanding parturition's inflammatory basis is crucial for preterm birth research.
  • Integrating preterm birth history into medical surveillance is recommended.
  • Increased funding and international collaboration are vital for advancing preterm birth prevention and treatment.

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K
Increased Intracranial Pressure ll: Pathophysiology01:29

Increased Intracranial Pressure ll: Pathophysiology

Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins...
43
Atelectasis II: Pathophysiology01:10

Atelectasis II: Pathophysiology

Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through...
75
Intrauterine Drug Delivery Systems01:21

Intrauterine Drug Delivery Systems

Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
170
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
75
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K